In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...

A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it ...

Annual Meeting, James Song, MD, chief medical officer and director of clinical research, Frontier Dermatology, outlines maj ...

Pfizer’s CDK4 inhibitor, atirmociclib, is already being investigated in a Phase III trial as a first-line therapy.

The FDA approved icotrokinra for adults and adolescents aged 12 years and older with moderate to severe plaque psoriasis, Johnson & Johnson announced in a press release. Icotrokinra (Icotyde) is the ...

In this episode, ‘Assessing Clinical and Economic Factors in Treatment Selection and Payer Decision-Making,’ the panelists ...

Laurel Smiles Dental Care has expanded its restorative and orthodontic treatment services in Laurel, Maryland, increasing ...

A clinical trial in China testing ICP-538, a treatment candidate for MS and other autoimmune diseases, has dosed its first healthy volunteer.

A bacterium associated with gum disease may contribute to the development and spread of breast cancer. Scientists have found that the microorganism is able to penetrate breast tissue through the ...

A two-week-old baby was hospitalized at Wolfson after contracting herpes during a circumcision involving direct oral suction.

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) ...